TW577889B - Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity - Google Patents

Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity Download PDF

Info

Publication number
TW577889B
TW577889B TW088121089A TW88121089A TW577889B TW 577889 B TW577889 B TW 577889B TW 088121089 A TW088121089 A TW 088121089A TW 88121089 A TW88121089 A TW 88121089A TW 577889 B TW577889 B TW 577889B
Authority
TW
Taiwan
Prior art keywords
methyl
pyridine
chloro
lhf
imidazo
Prior art date
Application number
TW088121089A
Other languages
English (en)
Chinese (zh)
Inventor
Hiroshi Kayakiri
Yoshito Abe
Hitoshi Hamashima
Hitoshi Sawada
Naoki Ishibashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW577889B publication Critical patent/TW577889B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW088121089A 1998-12-04 1999-12-02 Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity TW577889B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34617598 1998-12-04
JP36754098 1998-12-24
JP25928399 1999-08-09

Publications (1)

Publication Number Publication Date
TW577889B true TW577889B (en) 2004-03-01

Family

ID=27334802

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088121089A TW577889B (en) 1998-12-04 1999-12-02 Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity

Country Status (15)

Country Link
US (2) US6573274B1 (cs)
EP (1) EP1136492A4 (cs)
KR (1) KR20010086593A (cs)
CN (1) CN1335847A (cs)
AR (1) AR021542A1 (cs)
AU (1) AU769890B2 (cs)
BR (1) BR9916919A (cs)
CA (1) CA2352871A1 (cs)
CZ (1) CZ20011981A3 (cs)
HK (1) HK1044154A1 (cs)
HU (1) HUP0104549A3 (cs)
IL (1) IL143439A0 (cs)
TR (1) TR200101568T2 (cs)
TW (1) TW577889B (cs)
WO (1) WO2000034277A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000372A1 (fr) * 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfamides et leur utilisation medicale
HUP0300725A3 (en) * 2000-08-11 2005-11-28 Pfizer Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
TW200533336A (en) * 2004-03-02 2005-10-16 Fujisawa Pharmaceutical Co Concomitant drugs
CA2675265A1 (en) * 2007-02-06 2008-07-14 Cipla Limited Process for the preparation of ethyl-n-(2, 3-dichloro-6-nitrobenzyl) glycine hydrochloride
WO2014123203A1 (ja) * 2013-02-06 2014-08-14 京都薬品工業株式会社 糖尿病治療薬
GB201321741D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
US9067914B1 (en) * 2013-12-10 2015-06-30 Genzyme Corporation Tropomyosin-related kinase (TRK) inhibitors
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215994A (en) 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
EP0503838A3 (en) * 1991-03-08 1992-10-07 Merck & Co. Inc. Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
US5128327A (en) 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
WO1993019067A1 (en) * 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
EP0882718B1 (en) 1995-12-28 2005-08-31 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
WO1999000359A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Aromatic ring derivatives
WO1999000372A1 (fr) * 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfamides et leur utilisation medicale

Also Published As

Publication number Publication date
HUP0104549A2 (hu) 2002-04-29
IL143439A0 (en) 2002-04-21
HK1044154A1 (zh) 2002-10-11
AR021542A1 (es) 2002-07-24
KR20010086593A (ko) 2001-09-13
EP1136492A4 (en) 2002-03-27
WO2000034277A1 (en) 2000-06-15
CN1335847A (zh) 2002-02-13
AU1414100A (en) 2000-06-26
US20030171396A1 (en) 2003-09-11
TR200101568T2 (tr) 2001-10-22
AU769890B2 (en) 2004-02-05
EP1136492A1 (en) 2001-09-26
BR9916919A (pt) 2002-01-15
CA2352871A1 (en) 2000-06-15
CZ20011981A3 (cs) 2002-01-16
US6573274B1 (en) 2003-06-03
HUP0104549A3 (en) 2002-12-28
US6890934B2 (en) 2005-05-10

Similar Documents

Publication Publication Date Title
AU2021232806B2 (en) Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
AU2006302135B2 (en) Kinase inhibitors
TWI567066B (zh) 蛋白質激酶抑制劑
AU774262B2 (en) Substituted pyrazoles as p38 kinase inhibitors
JP6356782B2 (ja) タンパク質キナーゼ阻害剤
EP1812439B1 (en) Kinase inhibitors
CN105732614B (zh) 磺酰胺基芳基炔类化合物及其用途
AU2014241152A1 (en) Benzimidazolone derivatives as bromodomain inhibitors
US20080153869A1 (en) Kinase Inhibitors
ES2750791T3 (es) Derivados de indolizina como inhibidores de fosfoinositido 3-quinasas
OA12058A (en) 5-(2-Substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazoloÄ4,3-DÜpyrimidin-7-ones as phosphodiesterase inhibitors.
CA2887203A1 (en) 2,3-(hetero)aryl substituted pyridinyl compounds and their use as gdf-8 inhibitors
AU2012308570A1 (en) Indazole-3-carboxamides and their use as Wnt/b-catenin signaling pathway inhibitors
CA2935867A1 (en) Heteroaryls and uses thereof
CA2758958A1 (en) Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors
KR20170098324A (ko) 특정 트리아졸로피리딘 및 트리아졸로피라진, 이들의 조성물 및 이들의 사용 방법
EP4168401B1 (en) Sulphonamide compounds
CN105906621A (zh) 用作fgfr抑制剂的乙醇类化合物
TW201144309A (en) Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
WO2000034277A1 (en) Sulfonamide compounds and uses thereof as medicines
CA2908824A1 (en) Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereof
WO2017108203A1 (en) Novel substituted indoline compounds as phosphodiesterase inhibitors
TW202425978A (zh) C5ar1拮抗劑及其用途
CN102887867B (zh) 一类三嗪类化合物、该化合物的制备方法及其用途
CN116655626B (zh) 一种含咪唑并[l,2-a]吡啶骨架的环丙二酰胺化合物及其制备方法和用途

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees